Literature DB >> 9566784

Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.

N Nagvekar1, L W Jacobson, N Willcox, A Vincent.   

Abstract

Most thymic epithelial tumours that associate with MG express an epitope that resembles the sequence alpha373-380 from the cytoplasmic loop of the acetylcholine receptor (AChR). It has been proposed that sensitization to this linear epitope initiates autoimmunity to the AChR in thymoma-associated MG. We therefore tested whether MG/thymoma patients have T cell responses or antibodies to this region of the AChR. We found no significant recognition of the alpha309-417 region by their thymoma or peripheral blood T cells, or by their serum anti-AChR antibodies. Instead, the T cell epitopes that were recognized, like the previously characterized B cell epitopes, were in the extracellular AChR domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566784      PMCID: PMC1904952          DOI: 10.1046/j.1365-2249.1998.00556.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor.

Authors:  T Barkas; A Mauron; B Roth; C Alliod; S J Tzartos; M Ballivet
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

2.  Location of antigenic determinants on primary sequences of subunits of nicotinic acetylcholine receptor by peptide mapping.

Authors:  M Ratnam; P B Sargent; V Sarin; J L Fox; D L Nguyen; J Rivier; M Criado; J Lindstrom
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

3.  Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.

Authors:  T Kirchner; S Tzartos; F Hoppe; B Schalke; H Wekerle; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

4.  Synthetic peptides used to locate the alpha-bungarotoxin binding site and immunogenic regions on alpha subunits of the nicotinic acetylcholine receptor.

Authors:  S Ralston; V Sarin; H L Thanh; J Rivier; J L Fox; J Lindstrom
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

5.  Antibody heterogeneity and specificity in myasthenia gravis.

Authors:  A Vincent; P J Whiting; M Schluep; F Heidenreich; B Lang; A Roberts; N Willcox; J Newsom-Davis
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 6.  Pathogenesis of myasthenia gravis.

Authors:  A Marx; A Wilisch; A Schultz; S Gattenlöhner; R Nenninger; H K Müller-Hermelink
Journal:  Virchows Arch       Date:  1997-05       Impact factor: 4.064

Review 7.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

8.  Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.

Authors:  N Sommer; N Willcox; G C Harcourt; J Newsom-Davis
Journal:  Ann Neurol       Date:  1990-09       Impact factor: 10.422

9.  Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment.

Authors:  P J Whiting; A Vincent; J Newsom-Davis
Journal:  Neurology       Date:  1986-05       Impact factor: 9.910

10.  Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?

Authors:  N Willcox; M Schluep; M A Ritter; H J Schuurman; J Newsom-Davis; B Christensson
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

View more
  3 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients.

Authors:  S J Tzartos; M Remoundos
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.